Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer

Neoadjuvant cisplatin‐based chemotherapy (NAC; 70 mg/m(2)) is standard of care for muscle‐invasive bladder carcinoma (MIBC). Many patients (pts) cannot receive cisplatin because of renal impairment, and administration of cisplatin 35 mg/m(2) on day 1 + 8 or 1 + 2 (i.e., split schedule) is a commonly...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Osterman, Chelsea K., Babu, Dilip S., Geynisman, Daniel M., Lewis, Bianca, Somer, Robert A., Balar, Arjun V., Zibelman, Matthew R., Guancial, Elizabeth A., Antinori, Gianna, Yu, Shun, Narayan, Vivek, Guzzo, Thomas J., Plimack, Elizabeth R., Vaughn, David J., Fung, Chunkit, Mamtani, Ronac
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Inc. 2019
Fag:
Brief Communications
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516116/
https://ncbi.nlm.nih.gov/pubmed/30728277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0561
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker